Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications

Journal of Liposome Research

Volumn 23, Issue 4, 2013, Pages 255-267

  Chattopadhyay, Saptarshi ^a,b  

^a Massachusetts Institute of Technology   (United States)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Aerosol surface charge; Aggregation; Leakage; Membrane rupture; Size distribution; Systemic drug

Indexed keywords

CIPROFLOXACIN; DOXORUBICIN; DRUG CARRIER; LIPOSOME;

AEROSOL; BILAYER MEMBRANE; BIOCOMPATIBILITY; BREATH HOLDING; CAPILLARY PRESSURE; CAPILLARY TUBE; CONCENTRATION RESPONSE; DEGRADATION; DIELECTRIC CONSTANT; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DRY POWDER INHALER; ELECTRIC POTENTIAL; ELECTROSTATIC PRECIPITATION; ENCAPSULATION; FREEZE DRYING; HYDRODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; INSULIN TREATMENT; LIPID BILAYER; LIPID COMPOSITION; LIPID MEMBRANE; LUNG ALVEOLUS MACROPHAGE; PARTICLE SIZE; PATIENT COMPLIANCE; PHASE TRANSITION; PRIORITY JOURNAL; REVIEW; SEDIMENTATION; STATIC ELECTRICITY; SUPERCRITICAL FLUID; SURFACE CHARGE; SURFACE PROPERTY; SURFACE TENSION; SUSPENSION; VIRUS VIABILITY; WATER PERMEABILITY;

AEROSOLS; COLLOIDS; DRUG CARRIERS; HUMANS; LIPOSOMES; LUNG;

EID: 84885441526     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2013.802332     Document Type: Review

References (130)

1. Anabousi VS. (2006). Liposomal drug carrier systems for inhalation treatment of lung cancer. Chemie, pharmazie, bio- und werkstoffwissenschaften. Saarbrücken, der universität des saarlandes.
2. Azarmi S, Roa WH, Loebenberg R. (2008). Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev 60:863-75.
3. Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13: 38-252.
4. Behr J, Zimmermann G, Baumgartner R, et al. (2009). Lung deposition of a liposomal cyclosporine a inhalation solution in patients after lung transplantation. J Aerosol Med Pulmonary Drug Deliv 22:121-29.
5. Bernard AL, Guedeau-boudeville MA, Marchi-artzner V, et al. (2005). Shear-induced permeation and fusion of lipid vesicles. J Coll Interface Sci 287:298-306. (Pubitemid 40725670)
6. Betageri GV, Parsons DL. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharmaceut 81:235-41.
7. Bhattacharya S, Haldar S. (2000). Interactions between cholesterol and lipids in bilayer membranes. Role of lipid headgroup and hydrocarbon chain-backbone linkage. Biochim Biophys Acta-Biomembr 1467: 39-53. (Pubitemid 30621583)
8. Boas U, Heegaard PMH. (2004). Dendrimers in drug research. Chem Soc Rev 33:43-63. (Pubitemid 38376610)
9. Borm PJA, Kreyling W. (2004). Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J Nanosci Nanotechnol 4:521-31. (Pubitemid 39387404)
10. Brain JD. (1992). Mechanisms, measurement, and significance of lung macrophage function. Environ Health Perspect 97:5-10.
11. Brain JD. (2007). Inhalation, deposition, and fate of insulin and other therapeutic proteins. Diabet Technol Therapeut 9:s4-15.
12. Bridges PA, Taylor KMG. (1998). Nebulisers for the generation of liposomal aerosols. Int J Pharmaceut 173:117-25. (Pubitemid 29027766)
13. Bridges PA, Taylor KMG. (2000). An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharmaceut 204:69-79.
14. Bunjes H. (2010). Lipid nanoparticles for the delivery of poorly watersoluble drugs. J Pharm Pharmacol 62:1637-45.
15. Chadha TS, Chattopadhyay S, Venkataraman C, Biswas P. (2012). Study of the charge distribution on liposome particles aerosolized by air-jet atomization. J Aerosol Med Pulmon Drug Deliv 25:355-64.
16. Chan HK, Gonda I. (1988). Development of a systematic theory of suspension inhalation aerosols. 2. Aggregates of monodisperse particles nebulized in polydisperse droplets. Int J Pharmaceut 41: 147-57. (Pubitemid 18017616)
17. Chattopadhyay S, Ehrman SH, Bellare J, Venkataraman C. (2012). Morphology and bilayer integrity of small liposomes during aerosol generation by airjet nebulisation. J Nanoparticle Res 14:779, 1-15.
18. Chattopadhyay S, Modesto-lopez IB, Venkataraman C, Biswas P. (2010). Size distribution and morphology of liposome aerosols generated by two methodologies. Aerosol Sci Technol 44:972-82.
19. Chen DR, Pui DYH. (1997). Experimental investigation of scaling laws for electrospraying: dielectric constant effect. Aerosol Sci Technol 27: 367-80. (Pubitemid 27350020)
20. Chen DR, Pui DYH, Kaufman SL. (1995). Electrospraying of conducting liquids for monodisperse aerosol generation in the 4 nm to 1.8 mu-m diameter range. J Aerosol Sci 26:963-77.
21. Cheow WS, Hadinoto K. (2010). Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: modifications of standard nanoparticle preparation methods. Colloids Surfaces A-Physicochem Engin Aspect 370:79-86.
22. Chono S, Fukuchi R, Seki T, Morimoto K. (2009). Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery. J Control Release 137:104-9.
23. Chow AHL, Tong HHY, Chattopadhyay P, Shekunov BY. (2007). Particle engineering for pulmonary drug delivery. Pharmaceut Res 24: 411-37. (Pubitemid 46295160)
24. Clark AR, Egan M. (1994). Modeling the deposition of inhaled powdered drug aerosols. J Aerosol Sci 25:175-86. (Pubitemid 285991)
25. Cloupeau M, Prunetfoch B. (1989). Electrostatic spraying of liquids in cone-jet mode. J electrostatics 22:135-59.
26. Cohen BS, Xiong JQ, Asgharian B, Ayres L. (1995). Deposition of inhaled charged ultrafine particles in a simple tracheal model. J Aerosol Sci 26:1149-60.
27. Conley J, Yang HM, Wilson T, et al. (1997). Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against francisella tularensis infection in mice. Antimicrob Agents Chemother 41:1288-92.
28. Dailey LA, Schmehl T, Gessler T, et al. (2003). Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. J Control Rel 86: 131-44. (Pubitemid 35461980)
29. Dandekar P, Venkataraman C, Mehra A. (2010). Pulmonary targeting of nanoparticle drug matrices. J Aerosol Med Pulmon Drug Deliv 23: 343-53.
30. Davies LA, Hannavy K, Davies N, et al. (2005). Electrohydrodynamic comminution: a novel technique for the aerosolisation of plasmid DNA. Pharmaceut Res 22:1294-304. (Pubitemid 41176033)
31. Delmas T, Fraichard A, Bayle P, et al. (2012). Encapsulation and release behavior from lipid nanoparticles: model study with nile red fluorophore. J Coll Sci Biotechnol 1:16-25.
32. Deng WW, Klemic JF, Li X, et al. (2006). Increase of electrospray throughput using multiplexed microfabricated sources for the scalable generation of monodisperse droplets. J Aerosol Sci 37:696-714.
33. Desai TR, Hancock REW, Finlay WH. (2002). A facile method of delivery of liposomes by nebulization. J Control Rel 84:69-78. (Pubitemid 35223415)
34. Desai TR, Hancock REW, Finlay WH. (2003). Delivery of liposomes in dry powder form: aerodynamic dispersion properties. Eur J Pharmaceut Sci 20:459-67. (Pubitemid 37491439)
35. Dhand R. (2004). New frontiers in aerosol delivery during mechanical ventilation. Respiratory Care 49:666-77.
36. Dilraj A, Cutts FT, de castro JF, et al. (2000). Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 355:798-803. (Pubitemid 30128820)
37. Dolovich MB, Ahrens RC, Hess DR, et al. (2005). Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest 127: 335-71.
38. Edwards DA, Ben-jebria A, Langer R. (1998). Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol 85:379-85. (Pubitemid 28365799)
39. Elhissi AMA, Faizi M, Naji WF, et al. (2007). Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. Int J Pharmaceut 334:62-70. (Pubitemid 46400313)
40. Epstein H, Afergan E, Moise T, et al. (2006). Number-concentration of nanoparticles in liposomal and polymeric multiparticulate preparations: empirical and calculation methods. Biomaterials 27:651-59. (Pubitemid 41464261)
41. Farr SJ, Kellaway IW, Parryjones DR, Woolfrey SG. (1985). Technetium-99m as a marker of liposomal deposition and clearance in the human-lung. Int J Pharmaceut 26:303-16. (Pubitemid 16228628)
42. Fernandez de la mora J, Loscertales IG. (1994). The current emitted by highly conducting taylor cones. J Fluid Mechanics 260:155-84. (Pubitemid 279257)
43. Fink JB. (2000). Aerosol device selection: evidence to practice. Respiratory Care 45:874-85.
44. Gagnadoux F, Hureaux J, Vecellio L, et al. (2008). Aerosolized chemotherapy. J Aerosol Med Pulmon Drug Deliv 21:61-69.
45. Ganan-Calvo AM. (1994). The size and charge of droplets in the electrospraying of polar liquids in cone-jet mode, and the minimum droplet size. J Aerosol Sci 25:s309-10.
46. Gaspar MM, Bakowsky U, Ehrhardt C. (2008). Inhaled liposomescurrent strategies and future challenges. J Biomed Nanotechnol 4: 245-57.
47. Gaspar MM, Gobbo O, Ehrhardt C. (2010). Generation of liposome aerosols with the aeroneb pro and the aeroprobe nebulizers. J Liposome Res 20:55-61.
48. Gilbert BE, Six HR, Wilson S, et al. (1988). Small particle aerosols of enviroxime-containing liposomes. Antiviral Res 9:355-65. (Pubitemid 19001083)
49. Gomez A. (2002). The electrospray and its application to targeted drug inhalation. Respiratory care 47:1419-31.
50. Gomez A, Bingham D, de Juan L, Tang K. (1998). Production of protein nanoparticles by electrospray drying. J Aerosol Sci 29:561-74. (Pubitemid 28263563)
51. Gonnet M, Bastiat G, Ivanova T, Boury F. (2012). Interfacial organization of -carotene loaded lipid nanocapsules modelized by 2d rheological measurements and electrophoretic mobility. J Coll Sci Biotechnol 1:137-46.
52. Gradon L, Marijnissen J. (2003). Optimizing of aerosol drug delivery. Dordrecht, The Netherlands: Kluwer Academic.
53. Gruner SM, Lenk RP, Janoff AS, Ostro MJ. (1985). Novel multilayered lipid vesicles-comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. Biochemistry 24: 2833-42.
54. Harishchandra RK, Saleem M, Galla HJ. (2010). Nanoparticle interaction with model lung surfactant monolayers. J Royal Soc Interface 7: s15-26.
55. Hashizaki K, Taguchi H, Sakai H, et al. (2006). Carboxyfluorescein leakage from poly(ethylene glycol)-grafted liposomes induced by the interaction with serum. Chem Pharmaceut Bull 54:80-84. (Pubitemid 43036754)
56. Heyder J, Gebhart J, Rudolf G, et al. (1986). Deposition of particles in the human respiratory-tract in the size range 0.005-15-mu-m. J Aerosol Sci 17:811-25. (Pubitemid 17492310)
57. Hinds WC. (1999). Aerosol technology: properties, behavior, and measurement of airborne particles. Hoboken (NJ): John Wiley & Sons.
58. Hofmann W. (2011). Modelling inhaled particle deposition in the human lung-a review. J Aerosol Sci 42:693-724.
59. Hofmann W, Koblinger L. (1990). Monte-Carlo modeling of aerosol deposition in human lungs. 2. Deposition fractions and their sensitivity to parameter variations. J Aerosol Sci 21:675-88.
60. Hogan CJ, Biswas P, Chen DR. (2009). Charged droplet dynamics in the submicrometer size range. J Phys Chem B 113:970-76.
61. Hogan CJ, Kettleson EM, Ramaswami B, et al. (2006). Charge reduced electrospray size spectrometry of mega- and gigadalton complexes: whole viruses and virus fragments. Anal Chem 78:844-52. (Pubitemid 43228592)
62. Hogan CJ, Yun KM, Chen DR, et al. (2007). Controlled size polymer particle production via electrohydrodynamic atomization. Colloids Surfaces A-Physicochem Engin Aspect 311:67-76. (Pubitemid 350026285)
63. Hossann M, Wang TT, Wiggenhorn M, et al. (2010). Size of thermosensitive liposomes influences content release. J Control Rel 147:436-43.
64. Huang YY, Wang CH. (2006). Pulmonary delivery of insulin by liposomal carriers. J Control Rel 113:9-14.
65. Jaafar-Maalej C, Andrieu V, Elaissari A, Fessi H. (2011). Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release. J Nanosci Nanotechnol 11:1841-51.
66. Jaafar-maalej C, Elaissari A, Fessi H. (2012). Lipid-based carriers: manufacturing and applications for pulmonary route. Expert Opin Drug Deliv 9:1111-27.
67. Johnson ACJH, Greenwood P, Hagstrom M, et al. (2008). Aggregation of nanosized colloidal silica in the presence of various alkali cations investigated by the electrospray technique. Langmuir 24: 12798-806.
68. Johnson DL, Carlson KD, Pearce TA, et al. (1999). Effects of nebulization time and pressure on lipid microtubule suspension and aerosol. Aerosol Sci Technol 30:211-22. (Pubitemid 32000897)
69. Jores K, Haberland A, Wartewig S, et al. (2005). Solid lipid nanoparticles (sln) and oil-loaded sln studied by spectrofluorometry and raman spectroscopy. Pharmaceut Res 22:1887-97. (Pubitemid 41504342)
70. Kim K, Kim W, Yun S, et al. (2008). Use of an electrospray for the generation of bacterial bioaerosols. J Aerosol Sci 39:365-72.
71. Kirby C, Gregoriadis G. (1984). Dehydration-rehydration vesicles-a simple method for high-yield drug entrapment in liposomes. Bio-technology 2:979-84. (Pubitemid 15090594)
72. Kleemann E, Schmehl T, Gessler T, et al. (2007). Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. Pharmaceut Res 24:277-87. (Pubitemid 46072187)
73. Kleinstreuer C, Zhang Z. (2011). Optimal drug-aerosol delivery to predetermined lung sites. J Heat Trans-Trans Asme 133:011002, 1-12.
74. Koblinger L, Hofmann W. (1990). Monte-Carlo modeling of aerosol deposition in human lungs. 1. Simulation of particle-transport in a stochastic lung structure. J Aerosol Sci 21: 661-74.
75. Kreyling WG, Hirn S, Schleh C. (2010). Nanoparticles in the lung. Nat Biotechnol 28:1275-76.
76. Labiris NR, Dolovich MB. (2003). Pulmonary drug delivery. Part i: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 56:588-99. (Pubitemid 37491710)
77. Laouini A, Jaafar-maalej C, Limayem-blouza I, et al. (2012). Preparation, characterization and applications of liposomes: state of the art. J Coll Sci Biotechnol 1:147-68.
78. Lasic DD. (1993). Liposomes from physics to application. Amsterdam: Elsevier.
79. Le brun PPH, de boer AH, Heijerman HGM, Frijlink HW. (2000). A review of the technical aspects of drug nebulization. Pharmacy World Sci 22:75-81.
80. Lentz YK, Worden LR, Anchordoquy TJ, Lengsfeld CS. (2005). Effect of jet nebulization on DNA: identifying the dominant degradation mechanism and mitigation methods. J Aerosol Sci 36: 973-90. (Pubitemid 40968174)
81. Levin Y, Idiart M.A. (2004). Pore dynamics of osmotically stressed vesicles. Physica a-statistical mechanics and its applications 331: 571-78.
82. Li ZL, Zhang YL, Wurtz W, et al. (2008). Characterization of nebulized liposomal amikacin (arikace (tm)) as a function of droplet size. J Aerosol Med Pulmon Drug Deliv 21:245-53.
83. Liang E, Hughes JA. (1998). Membrane fusion and rupture in liposomes: effect of biodegradable ph-sensitive surfactants. J Memb Biol 166: 37-49. (Pubitemid 28516082)
84. Lippmann M. (1990). Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect 88:311-17. (Pubitemid 20352988)
85. Liu FY, Shao ZZ, Kildsig DO, Mitra AK. (1993). Pulmonary delivery of free and liposomal insulin. Pharmaceut Res 10:228-32. (Pubitemid 23041736)
86. Mansour HM, Rhee YS, Wu XA. (2009). Nanomedicine in pulmonary delivery. Int J Nanomed 4:299-319.
87. Mayer LD, Bally MB, Hope M, Cullis PR. (1986). Techniques for encapsulating bioactive agents into liposomes. Chem Phys Lipids 40: 333-45. (Pubitemid 16040787)
88. Mccallion ONM, Taylor KMG, Thomas M, Taylor AJ. (1995). Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharmaceut Res 12: 1682-88.
89. Mccallion ONM, Taylor KMG, Thomas M, Taylor AJ. (1996a). The influence of surface tension on aerosols produced by medical nebulisers. Int J Pharmaceut 129:123-36. (Pubitemid 26097980)
90. Mccallion ONM, Taylor KMG, Thomas M, Taylor AJ. (1996b). Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers. Int J Pharmaceut 133:203-14. (Pubitemid 26160846)
91. Melandri C, Tarroni G, Prodi V, et al. (1983). Deposition of chargedparticles in the human airways. J Aerosol Sci 14:184-86.
92. Mezei M, Run O. (1995). Pain management with liposome-encapsulated analgesic drugs usp 5,451,408.
93. Mitsakou C, Helmis C, Housiadas C. (2005). Eulerian modelling of lung deposition with sectional representation of aerosol dynamics. J Aerosol Sci 36:75-94. (Pubitemid 39601425)
94. Nerbrink O, Dahlback M, Hansson HC. (1994). Why do medical nebulizers differ in their output and particle-size characteristics. J Aerosol Med-Depos Clear Effect Lung 7:259-76.
95. Niven RW, Brain JD. (1994). Some functional-aspects of air-jet nebulizers. Int J Pharmaceut 104:73-85.
96. Niven RW, Carvajal TM, Schreier H. (1992). Nebulization of liposomes 3. The effects of operating-conditions and local environment. Pharmaceut Res 9:515-20.
97. Niven RW, Schreier H. (1990). Nebulization of liposomes. 1. Effects of lipid-composition. Pharmaceut Res 7:1127-33.
98. Niven RW, Speer M, Schreier H. (1991). Nebulization of liposomes. 2. The effects of size and modeling of soute release profiles. Pharmaceut Res 8:217-21.
99. Ocallaghan C, Barry PW. (1997). The science of nebulised drug delivery. Thorax 52:s31-44. (Pubitemid 27239451)
100. Otterson GA, Villalona-calero MA, Sharma S, et al. (2007). Phase i study of inhaled doxorubicin for patients with metastatic tumors to the lungs. Clin Canc Res 13:1246-52.
101. Patton JS. (1996). Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3-36. (Pubitemid 26167852)
102. Patton JS, Brain JD, Davies LA, et al. (2010). The particle has landedcharacterizing the fate of inhaled pharmaceuticals. J Aerosol Med Pulmon Drug Deliv 23:s71-87.
103. Patton JS, Bukar J, Nagarajan S. (1999). Inhaled insulin. Adv Drug Deliv Rev 35:235-47. (Pubitemid 29073616)
104. Patton JS, Byron PR. (2007). inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67-74. (Pubitemid 46020287)
105. Perera AD, Kapitza C, Nosek L, et al. (2002). Absorption and metabolic effect of inhaled insulin-intrapatient variability after inhalation via the aerodose insulin inhaler in patients with type 2 diabetes. Diabetes Care 25:2276-81. (Pubitemid 41071040)
106. Perkins WR, Minchey SR, Ahl PL, Janoff AS. (1993). The determination of liposome captured volume. Chem Phys Lipids 64:197-217. (Pubitemid 23290874)
107. Reychler G, Keyeux A, Cremers C, et al. (2004). Comparison of lung deposition in two types of nebulization-intrapulmonary percussive ventilation vs jet nebulization. Chest 125:502-08. (Pubitemid 38223629)
108. Rouge N, Buri P, Doelker E. (1996). Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharmaceut 136:117-39. (Pubitemid 26199405)
109. Saari M, Vidgren MT, Koskinen MO, et al. (1999). Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int J Pharmaceut 181:1-9. (Pubitemid 29199882)
110. Sabin J, Prieto G, Ruso JM, et al. (2006). Size and stability of liposomes: a possible role of hydration and osmotic forces. Eur Phys Journal E 20:401-8. (Pubitemid 44386800)
111. Schulz H. (1998). Mechanisms and factors affecting intrapulmonary particle deposition: implications for efficient inhalation therapies. Pharmaceut Sci Technol Today 1:336-44. (Pubitemid 28526962)
112. Semmler-behnke M, Kreyling WG, Lipka J, et al. (2008). Biodistribution of 1.4-and 18-nm gold particles in rats. Small 4:2108-11.
113. Sharma A, Sharma US. (1997). Liposomes in drug delivery: progress and limitations. Int J Pharmaceut 154:123-40. (Pubitemid 27351317)
114. Stahlhofen W, Armbruster L, Gebhart J, Grein E. (1975). Particle sizing of aerosols by single-particle observation in a sedimentation cell. Atmos Environ 9:851-57.
115. Szoka F, Papahadjopoulos D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75:4194-98.
116. Tang K, Gomez A. (1994). Generation by electrospray of monodisperse water droplets for targeted drug-delivery by inhalation. J Aerosol Sci 25:1237-49.
117. Telko MJ, Hickey AJ. (2005). Dry powder inhaler formulation. Respiratory Care 50:1209-27.
118. Vaaraslahti K, Laitinen A, Keskinen J. (2002). Spray charging of droplets in a wet scrubber. J Air Waste Manage Assoc 52:175-80. (Pubitemid 34131092)
119. Valdespino-gomez JL, Sepulveda-amor J, Garcia-garcia MD, et al. (2002). A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (mr) vaccines in school age children. Vaccine 20:2790-95.
120. Vanbever R, Mintzes JD, Wang J, et al. (1999). Formulation and physical characterization of large porous particles for inhalation. Pharmaceut Res 16:1735-42.
121. Verschraegen CF, Gilbert BE, Loyer E, et al. (2004). Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)- camptothecin in patients with advanced pulmonary malignancies. Clin Canc Res 10:2319-26.
122. Wadell C. (2002). Nasal drug delivery- in vitro studies on factors influncing permeability and implications on absorption. Faculty of pharmacy in pharmaceutics. Uppsala: Acta Universitatis Upsaliensis.
123. Waldrep JC, Arppe J, Jansa KA, KnightV. (1997). High dose cyclosporin a and budesonide-liposome aerosols. Int J Pharmaceut 152:27-36. (Pubitemid 27254958)
124. Waldrep JC, Keyhani K, Black M, Knight V. (1994). Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 105:106-10. (Pubitemid 24029086)
125. Weers J, Metzheiser B, Taylor G, et al. (2009). A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulmon Drug Deliv 22:131-38.
126. Weibel ER. (2009). What makes a good lung? Swiss MedWeekly, p. 139.
127. Wu Y, Yu B, Jackson A, et al. (2009). Coaxial electrohydrodynamic spraying: a novel one-step technique to prepare oligodeoxynucleotide encapsulated lipoplex nanoparticles. Mol Pharmaceut 6:1371-79.
128. Yurteri CU, Hartman RPA, Marijnissen JCM. (2010). Producing pharmaceutical particles via electrospraying with an emphasis on nano and nano structured particles-a review. Kona Powd Part J 91-115.
129. Zachariah MR, Li MD, Guha S, et al. (2011). Quantification and compensation of nonspecific analyte aggregation in electrospray sampling. Aerosol Sci Technol 45:849-60.
130. Zhang L, Pornpattananangku D, Hu C-MJ, Huang C-M. (2010). Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17:585-94.